Compare HCA Health Inc (HCA) vs Hormel Foods Corp (HRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Hormel Foods Corp — how do they compare? HCA Health Inc trades at $443.75 (market cap $96.35B), while Hormel Foods Corp trades at $19.44 (market cap $10.69B). The key difference: HCA Health Inc is far larger — about 9× Hormel Foods Corp's market cap, and Hormel Foods Corp pays the higher dividend (6.02%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Hormel Foods Corp for 99 Days on average.
| HCA | HRL | |
|---|---|---|
Market Cap | $96.35B | $10.69B |
Volume | 1,079,453 | 10,041,387 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $26.50 |
52-Week Low | $361.32 | $19.42 |
Typical Hold Time | 76 Days | 99 Days |
Enterprise Value | $146.88B | $12.67B |
Dividend Yield | 0.7% | 6.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
Hormel Foods (HRL) trades at $19.55, down 1.66% on the day, with a bearish technical signal from moving averages. The company reported a net income margin of 2.82% for 2025, with recent quarterly EPS beats but a year-over-year decline in net income. Its acquisition of Brakebush for $1.06 billion aims to expand its foodservice chicken business, while the dividend yield remains a key attraction as a Dividend King.
The stock presents a mixed outlook: analyst consensus targets $24.25 imply upside, but high P/E of 31.53 and shrinking profit margins pose valuation and growth concerns. Risks include execution on acquisitions and consumer spending pressures, yet the strong dividend history offers income stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
